Guide fiduciary responsibilities to develop robust governance frameworks, board policies, and practices to ensure necessary transparency and accountability.

Investor networking within the Australia private equity and high-net-worth communities, including investor pitch deck development and delivery.

Deal structure process and banker and financial advisor consulting.

Investor relations strategy, news flow, equity research and roadshow advisory.

Investor advisory based on expected commercial returns: We translate the complexities of Healthtech commercialisation into a succinct dashboard to guide investment decisions.

Identify and address the “real hurdles” holding back the business from market traction and growth.

Break out of the R&D ditch: true and honest assessment blocking your commercial success.

Pivoting from R&D driven to a “commercially obsessed” company pulling organisational, cultural, clinical, business development, and operational levers to drive market entry plans and revenue growth initiatives.

Business Development and Corporate Partnerships introduction and facilitation of commercial agreements and contracts, strategic alliances, and private equity financed mergers or acquisitions.

Partner commercial agreements spotlighting the critical near and long-term business impact.

Driving widespread adoption in clinical practice as the standard of care by going beyond the science, regulatory and reimbursement hurdles to successfully scale-up.

Implementation Science – adopting, adapting and sustaining integration of evidence-based practices, interventions, and policies to get your business into routine healthcare usage.